NBY

NovaBay Pharmaceuticals (NBY)

About NovaBay Pharmaceuticals (NBY)

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Details

Daily high

$0.64

Daily low

$0.61

Price at open

$0.63

52 Week High

$14.18

52 Week Low

$0.36

Market cap

3.1M

Dividend yield

0.00%

Volume

104,725

Avg. volume

7.7M

P/E ratio

-.01

NovaBay Pharmaceuticals News